4//SEC Filing
Virnich Daniel 4
Accession 0001628280-25-027210
CIK 0001799191other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 2:22 PM ET
Size
5.1 KB
Accession
0001628280-25-027210
Insider Transaction Report
Form 4
Virnich Daniel
Chief Executive Officer
Transactions
- Disposition to Issuer
Common stock
2025-05-21$2.67/sh−20,388$54,538→ 1,787,309 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001891107
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 2:22 PM ET
- Size
- 5.1 KB